MX364562B - Terapia para hemorragia subaracnoidea e isquemia. - Google Patents
Terapia para hemorragia subaracnoidea e isquemia.Info
- Publication number
- MX364562B MX364562B MX2014007031A MX2014007031A MX364562B MX 364562 B MX364562 B MX 364562B MX 2014007031 A MX2014007031 A MX 2014007031A MX 2014007031 A MX2014007031 A MX 2014007031A MX 364562 B MX364562 B MX 364562B
- Authority
- MX
- Mexico
- Prior art keywords
- aneurysm
- subjects
- subarachnoid hemorrhage
- endovascular
- psd
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570264P | 2011-12-13 | 2011-12-13 | |
| CA2762338A CA2762338C (en) | 2011-12-13 | 2011-12-15 | Therapy for subarachnoid hemorrhage and ischemia |
| US201261617001P | 2012-03-28 | 2012-03-28 | |
| PCT/IB2012/057259 WO2013088382A1 (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007031A MX2014007031A (es) | 2015-02-20 |
| MX364562B true MX364562B (es) | 2019-04-30 |
Family
ID=51228598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007031A MX364562B (es) | 2011-12-13 | 2012-12-13 | Terapia para hemorragia subaracnoidea e isquemia. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2800575B1 (enExample) |
| JP (3) | JP6279483B2 (enExample) |
| KR (2) | KR102114490B1 (enExample) |
| CN (1) | CN104053448B (enExample) |
| AU (1) | AU2012354072B2 (enExample) |
| DK (1) | DK2800575T3 (enExample) |
| ES (1) | ES2731266T3 (enExample) |
| IL (1) | IL233103B (enExample) |
| MX (1) | MX364562B (enExample) |
| SG (2) | SG10201604676WA (enExample) |
| WO (1) | WO2013088382A1 (enExample) |
| ZA (1) | ZA201404636B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2440230B1 (en) | 2009-06-10 | 2020-11-11 | NoNO Inc. | Treatment regimes for treatment of neurological disease |
| PT2723363T (pt) | 2011-06-24 | 2018-11-08 | Nono Inc | Terapia de combinação para isquemia |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| JP6633523B2 (ja) * | 2013-12-01 | 2020-01-22 | ユニバーシティ オブ コペンハーゲン | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 |
| SMT202000307T1 (it) | 2014-05-28 | 2020-07-08 | Nono Inc | Sale cloruro di tat-nr2b9c |
| WO2017185250A1 (zh) * | 2016-04-27 | 2017-11-02 | 拜西欧斯（北京）生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗方法 |
| CN107312071B (zh) * | 2016-04-27 | 2018-11-06 | 拜西欧斯（北京）生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗方法 |
| CN109985047B (zh) * | 2017-12-29 | 2021-07-27 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用 |
| CN109009111A (zh) * | 2018-07-16 | 2018-12-18 | 重庆大学 | 低场核磁共振脑出血动态监护仪控制系统 |
| CN113284126B (zh) * | 2021-06-10 | 2022-06-24 | 安徽省立医院(中国科学技术大学附属第一医院) | 人工神经网络图像分析预测脑积水分流手术疗效的方法 |
| CN113735938B (zh) * | 2021-07-30 | 2024-11-08 | 英纳氏(珠海)药业有限公司 | 一种神经保护多肽化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510824B2 (en) | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| DK2120987T3 (en) * | 2007-03-02 | 2014-02-24 | Nono Inc | Treatment of stroke and other diseases without inhibiting N-type calcium channels |
| EP2440230B1 (en) * | 2009-06-10 | 2020-11-11 | NoNO Inc. | Treatment regimes for treatment of neurological disease |
-
2012
- 2012-12-13 WO PCT/IB2012/057259 patent/WO2013088382A1/en not_active Ceased
- 2012-12-13 DK DK12857611.3T patent/DK2800575T3/da active
- 2012-12-13 MX MX2014007031A patent/MX364562B/es active IP Right Grant
- 2012-12-13 KR KR1020147019192A patent/KR102114490B1/ko not_active Expired - Fee Related
- 2012-12-13 KR KR1020207014227A patent/KR20200057802A/ko not_active Ceased
- 2012-12-13 SG SG10201604676WA patent/SG10201604676WA/en unknown
- 2012-12-13 SG SG11201403239UA patent/SG11201403239UA/en unknown
- 2012-12-13 JP JP2014546717A patent/JP6279483B2/ja not_active Expired - Fee Related
- 2012-12-13 ES ES12857611T patent/ES2731266T3/es active Active
- 2012-12-13 CN CN201280061924.1A patent/CN104053448B/zh not_active Expired - Fee Related
- 2012-12-13 AU AU2012354072A patent/AU2012354072B2/en not_active Ceased
- 2012-12-13 EP EP12857611.3A patent/EP2800575B1/en active Active
-
2014
- 2014-06-12 IL IL233103A patent/IL233103B/en active IP Right Grant
- 2014-06-24 ZA ZA2014/04636A patent/ZA201404636B/en unknown
-
2017
- 2017-11-10 JP JP2017217549A patent/JP6741642B2/ja not_active Expired - Fee Related
-
2020
- 2020-05-15 JP JP2020085748A patent/JP2020128419A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020128419A (ja) | 2020-08-27 |
| KR20140108266A (ko) | 2014-09-05 |
| ZA201404636B (en) | 2015-10-28 |
| EP2800575B1 (en) | 2019-05-22 |
| KR20200057802A (ko) | 2020-05-26 |
| SG11201403239UA (en) | 2014-09-26 |
| JP2018052962A (ja) | 2018-04-05 |
| ES2731266T3 (es) | 2019-11-14 |
| AU2012354072A1 (en) | 2014-07-03 |
| DK2800575T3 (da) | 2019-07-01 |
| JP6279483B2 (ja) | 2018-02-14 |
| JP6741642B2 (ja) | 2020-08-19 |
| EP2800575A1 (en) | 2014-11-12 |
| KR102114490B1 (ko) | 2020-05-25 |
| MX2014007031A (es) | 2015-02-20 |
| AU2012354072B2 (en) | 2017-04-27 |
| EP2800575A4 (en) | 2015-09-23 |
| CN104053448B (zh) | 2017-04-05 |
| IL233103A0 (en) | 2014-07-31 |
| WO2013088382A1 (en) | 2013-06-20 |
| CN104053448A (zh) | 2014-09-17 |
| IL233103B (en) | 2021-03-25 |
| JP2015501834A (ja) | 2015-01-19 |
| SG10201604676WA (en) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014007031A (es) | Terapia para hemorragia subaracnoidea e isquemia. | |
| BR112014024287A2 (pt) | composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos | |
| MX2022002786A (es) | Inhibidores del reciclaje de acidos biliares para el tratamiento de colangitis esclerosante primaria y enfermedad inflamatoria intestinal. | |
| BR112015028482A2 (pt) | implante cirúrgico que compreende uma camada que tem aberturas | |
| MX2008013454A (es) | Metodos y equipos para la prediccion de riesgo en partos prematuros. | |
| BR112015004191A2 (pt) | chapa de aço | |
| MX2021013938A (es) | Metodos y composiciones para prediccion de eficacia terapeutica de tratamientos contra el cancer y prognosis del cancer. | |
| BR112015022218A2 (pt) | composições e sua utilização para tratar complicações da hemorragia subaracnóidea aneurismática | |
| TN2016000161A1 (en) | (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones as inhibitors of fibrinolysis | |
| SG10201510118VA (en) | Use of refrigerants comprising e-1,3,3,3-tetrafluoropropene and at least one tetrafluoroethane for cooling | |
| BR112015001521A2 (pt) | previsão de resposta ao tratamento para inibidor jak/stat | |
| EP3242136A3 (en) | Secretome profile-facilitated in vitro fertilization | |
| WO2006026557A3 (en) | Methods and kits for predicting risk for peterm labor | |
| RU2012149809A (ru) | Способ прогнозирования прогрессирования первичной открытоугольной глаукомы | |
| Macdonald | Whether subarachnoid hemorrhage depends on the weather? | |
| UA62588U (ru) | Способ хирургического лечения артериовенозных мальформаций головного мозга | |
| Macdonald | Dissecting the complexities of aneurysm hemodynamics | |
| 郭建明 | Surgical treatment of visceral artery aneurysms | |
| TN2013000526A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| EP2392338A4 (en) | PROPHYLACTIC OR THERAPEUTIC FOR DISEASES RELATED TO ABNORMAL BONE MATERIAL CHANGE | |
| CL2008001188A1 (es) | Proceso para la obtención de cloruros de ácido a partir de la reacción entre derivados de ácidos carboxílicos y cloruro de tionilo. | |
| MY175936A (en) | A use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vegina syndrome or colpoxerosis disease in an mammal | |
| UA84482C2 (ru) | Способ неотложного хирургического лечения пациентов с идиопатической тромбоцитопенической пурпурой, осложненной внутрибрюшным кровотечением | |
| FR2963832B1 (fr) | Procede de quantification de l'effet potentialisateur du fibrinogene sur la generation de thrombine et ses applications | |
| EP2722050A4 (en) | USE OF OLIVE OIL FOR THE PREVENTION AND TREATMENT OF DISEASES THROUGH ISCHEMIC PROCESSES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |